Oncology Medical News about symptomatic anemia

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lenalidomide is active in Japanese patients with symptomatic anemia in low- or intermediate-1 risk myelodysplastic syndromes with a deletion 5q abnormality
International Journal of Hematology, 08/27/09

Harada H et al. – The adverse events were manageable, and no patients experienced serious adverse events or adverse events requiring treatment discontinuation. The results indicate that lenalidomide can be a useful agent for treating Japanese patients with anemia associated with low– or intermediate–1 risk MDS with the del 5q cytogenetic abnormality.

<< Previous
Primary cutaneous anaplastic large cell lymphoma of the vulva: a...

Next >>
A study of rasburicase for the management of hyperuricemia in...

Anemia Myth Busters: Ice Chewing, Hair Loss and Lack of Sleep
Internet Source, 11/25/09 Relevance Score: 47%%

Iron-Refractory Iron Deficiency Anemia
Seminars in Hematology, 10/05/09 Relevance Score: 47%%

A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases
World Journal of Gastroenterology, 10/14/09 Relevance Score: 46%%

Prevalence and pathogenesis of anemia in Inflammatory Bowel disease. Influence of anti-tumor necrosis factor-alpha treatment
Haematologica, 10/12/09 Relevance Score: 46%%

Hereditary Sideroblastic Anemias: Pathophysiology, Diagnosis, and Treatment
Seminars in Hematology, 10/05/09 Relevance Score: 46%%